Not all flavoured condoms are created equal. Some sell more in south India, while others have found a niche in the north, per ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Mankind's revenue from operations rose to Rs 3,230 crore in Q3FY25, a 24 per cent Y-o-Y rise from Rs 2,607 crore reported in ...

Mankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue ...

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its ...

The funding issue was oversubscribed by 2.7 times and facilitated by InCred, with the company being valued at INR 1,000 crore (around USD 120 million).

India's Mankind Pharma reported a smaller-than-expected third-quarter profit on Thursday, hurt by a sharp rise in expenses.

NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out ...

Mankind Pharma Ltd.'s share price declined more than 5% during early trade on Friday after the company's third-quarter ...

Mankind Pharma's net profit fell 16.5% to Rs 384 crore in Q3 FY25, while revenue rose 24% to Rs 3,230 crore. The company's ...

Mankind Pharma's domestic business revenues grew by 16 per cent year-on-year, reaching Rs 2,773 crore in Q3FY25, compared to Rs 2,400 crore in Q3FY24. The company’s consumer healthcare segment saw a ...

Net profit of mankind Pharma declined by 16.2% to ₹380.2 crore compared with ₹453.8 crore in the corresponding quarter of the ...